Teneligliptin hydrobromide is an oral antidiabetic medication used for the treatment of type 2 diabetes mellitus. It is used to help control blood sugar levels in adults, typically as an adjunct to diet and exercise. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Teneligliptin hydrobromide anhydrous and Teneligliptin HBr. Its PubChem CID is 11996485.
Teneligliptin hydrobromide
| CAS No | 906093-29-6 |
|---|---|
| Molecular Formula | C44H65Br5N12O2S2 |
| Molecular Weight | 1257.7 g/mol |
| Synonyms | bis([(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone);pentahydrobromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Teneligliptin hydrobromide is an oral antidiabetic medication used for the treatment of type 2 diabetes mellitus. It is used to help control blood sugar levels in adults, typically as an adjunct to diet and exercise.
The listed CAS number is 906093-29-6.
The listed molecular formula is C44H65Br5N12O2S2.
The listed molecular weight is 1257.7 g/mol.
bis([(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone);pentahydrobromide.
The source lists Teneligliptin hydrobromide anhydrous and Teneligliptin HBr.